Table 1.
Conventional Cytology | CTC Analysis | ctDNA Analysis | |
---|---|---|---|
Method | Direct visualization and identification of neoplastic cells | Detection of tumor cells in CSF based on surface molecule expression | Analysis of DNA released from tumor cells within CSF |
Sensitivity | 44–67% from first lumbar puncture, increased with serial testing | 76–100% reported sensitivity for EpCAM-based detection | Not applicable |
Availability | Wide-spread, available for all tumor types | Limited, requires use of specialized equipment and personnel. | Limited |
Diagnostic Interpretation | Qualitative, can be inconclusive requiring serial lumbar punctures to establish diagnosis | Quantitative, but dependent on surface molecule expression | Not applicable |
Biomarker potential | Not applicable | Potential use for monitoring treatment response and prognostication | Potential use for detecting resistance mutations or progression |
Molecular genetics | Provides no information on tumor genetics | May be combined with downstream genetic testing to identify mutations and CSF clonal divergence | Can identify driver mutations and CSF clonal divergence |
CTCs, circulating tumor cells; ctDNA, cell-free tumor DNA; CSF, cerebrospinal fluid; LM, leptomeningeal metastasis.